161 related articles for article (PubMed ID: 25692294)
1. Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
Ouyang Q; Zhu L; Chen K; Su F
PLoS One; 2015; 10(2):e0118161. PubMed ID: 25692294
[TBL] [Abstract][Full Text] [Related]
2. Immediate postmastectomy reconstruction is associated with improved breast cancer-specific survival: evidence and new challenges from the Surveillance, Epidemiology, and End Results database.
Bezuhly M; Temple C; Sigurdson LJ; Davis RB; Flowerdew G; Cook EF
Cancer; 2009 Oct; 115(20):4648-54. PubMed ID: 19634163
[TBL] [Abstract][Full Text] [Related]
3. Diminished survival in patients with inner versus outer quadrant breast cancers.
Gaffney DK; Tsodikov A; Wiggins CL
J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
[TBL] [Abstract][Full Text] [Related]
4. Does Choice of Reconstruction Type Affect Survival in Patients With Metastatic Breast Cancer?
Qi X; Wang K; Sun D; Zhang L
J Surg Res; 2020 Mar; 247():479-489. PubMed ID: 31668432
[TBL] [Abstract][Full Text] [Related]
5. Immediate postmastectomy breast reconstruction showed limited advantage in patient survival after stratifying by family income.
Jiang YZ; Liu YR; Yu KD; Zuo WJ; Shao ZM
PLoS One; 2013; 8(12):e82807. PubMed ID: 24349366
[TBL] [Abstract][Full Text] [Related]
6. Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysis.
Wang M; Chen H; Wu K; Ding A; Zhang P; Zhang M
Breast Cancer Res Treat; 2019 Jul; 176(2):337-347. PubMed ID: 31020469
[TBL] [Abstract][Full Text] [Related]
7. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
8. Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data.
Fields RC; Jeffe DB; Deshpande AD; Feunou F; Krishna N; Margenthaler JA
J Surg Res; 2010 Jun; 161(2):183-9. PubMed ID: 19959188
[TBL] [Abstract][Full Text] [Related]
9. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
[TBL] [Abstract][Full Text] [Related]
10. Survival in breast cancer patients undergoing immediate breast reconstruction.
Agarwal S; Liu JH; Crisera CA; Buys S; Agarwal JP
Breast J; 2010; 16(5):503-9. PubMed ID: 20604794
[TBL] [Abstract][Full Text] [Related]
11. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
[TBL] [Abstract][Full Text] [Related]
12. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
13. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
[TBL] [Abstract][Full Text] [Related]
14. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
17. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
18. Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications.
Cowen D; Gross E; Rouannet P; Teissier E; Ellis S; Resbeut M; Tallet A; Cowen VV; Azria D; Hannoun-Levi JM
Breast Cancer Res Treat; 2010 Jun; 121(3):627-34. PubMed ID: 20424909
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
[TBL] [Abstract][Full Text] [Related]
20. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
